Insider · CIK 0001636168
C. David Nicholson
director
Files at ATNM (Actinium Pharmaceuticals, Inc.), ADVM (Adverum Biotechnologies, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | AGrant or award Common Stock | +62,800 | $0.00 | $0 | 63,300 | 38 d ago |
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +94,200 | $0.00 | $0 | 94,200 | 38 d ago |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,520 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | - | - | 0 | Dec 10, 2025 |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,450 | $0.00 | $0 | 10,450 | Jun 20, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,333 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,351 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -72,156 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,311 | $0.00 | $0 | 0 | Apr 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.